Mgi Tech Surges Over 19% as AI Enters Industrialization Phase, Company Provides Sequencing Tools for AI Drug Discovery

Stock News12:06

Mgi Tech Co.,Ltd. (688114.SH) surged over 19% in early trading, currently up 14.27% at 61.51 yuan with a turnover of 1.014 billion yuan.

AI for Science is transitioning from concept to an industrialization inflection point. Major North American tech firms are collectively doubling down on AI-driven drug development, with accelerated model training and expanded experimental demands feeding upstream. The innovative drug chain is now facing dual opportunities of value reassessment and incremental growth.

As a full-stack life science tools provider, Mgi Tech Co.,Ltd. holds a global leading position in full-read-length sequencer business, offering essential sequencing instruments for AI drug discovery. The company previously partnered with Zhuiguang Biotechnology and the National University of Singapore's Department of Pharmacy and Pharmaceutical Sciences in drug research and development.

Notably, Mgi Tech Co.,Ltd.'s subsidiary, Yongsheng Intelligence, recently jointly released two achievements with the Shanghai Artificial Intelligence Laboratory: ProtoPilot, a self-evolving multi-agent system driven by real laboratory scenarios, and BioLab Bench, the first full-process Agent evaluation system in life sciences from user requirements to executable equipment, delivering the inaugural Physical AI answer for global life science laboratories.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187311941?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-10 12:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187311941","market":"hk","top_or_hot":-1,"title":"Mgi Tech Surges Over 19% as AI Enters Industrialization Phase, Company Provides Sequencing Tools for AI Drug Discovery","media":"Stock News","content":"<p><b>Mgi Tech Co.,Ltd. (688114.SH)</b> surged over 19% in early trading, currently up 14.27% at 61.51 yuan with a turnover of 1.014 billion yuan.<br><br>AI for Science is transitioning from concept to an industrialization inflection point. Major North American tech firms are collectively doubling down on AI-driven drug development, with accelerated model training and expanded experimental demands feeding upstream. The innovative drug chain is now facing dual opportunities of value reassessment and incremental growth.<br><br>As a full-stack life science tools provider, <b>Mgi Tech Co.,Ltd.</b> holds a global leading position in full-read-length sequencer business, offering essential sequencing instruments for AI drug discovery. The company previously partnered with Zhuiguang Biotechnology and the National University of Singapore's Department of Pharmacy and Pharmaceutical Sciences in drug research and development.<br><br>Notably, <b>Mgi Tech Co.,Ltd.</b>'s subsidiary, Yongsheng Intelligence, recently jointly released two achievements with the Shanghai Artificial Intelligence Laboratory: ProtoPilot, a self-evolving multi-agent system driven by real laboratory scenarios, and BioLab Bench, the first full-process Agent evaluation system in life sciences from user requirements to executable equipment, delivering the inaugural Physical AI answer for global life science laboratories.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mgi Tech Surges Over 19% as AI Enters Industrialization Phase, Company Provides Sequencing Tools for AI Drug Discovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMgi Tech Surges Over 19% as AI Enters Industrialization Phase, Company Provides Sequencing Tools for AI Drug Discovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-10 12:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Mgi Tech Co.,Ltd. (688114.SH)</b> surged over 19% in early trading, currently up 14.27% at 61.51 yuan with a turnover of 1.014 billion yuan.<br><br>AI for Science is transitioning from concept to an industrialization inflection point. Major North American tech firms are collectively doubling down on AI-driven drug development, with accelerated model training and expanded experimental demands feeding upstream. The innovative drug chain is now facing dual opportunities of value reassessment and incremental growth.<br><br>As a full-stack life science tools provider, <b>Mgi Tech Co.,Ltd.</b> holds a global leading position in full-read-length sequencer business, offering essential sequencing instruments for AI drug discovery. The company previously partnered with Zhuiguang Biotechnology and the National University of Singapore's Department of Pharmacy and Pharmaceutical Sciences in drug research and development.<br><br>Notably, <b>Mgi Tech Co.,Ltd.</b>'s subsidiary, Yongsheng Intelligence, recently jointly released two achievements with the Shanghai Artificial Intelligence Laboratory: ProtoPilot, a self-evolving multi-agent system driven by real laboratory scenarios, and BioLab Bench, the first full-process Agent evaluation system in life sciences from user requirements to executable equipment, delivering the inaugural Physical AI answer for global life science laboratories.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01477","symbol_name":"欧康维视生物-B","start_time":0,"source_url":"","article_id":"1187311941","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187311941","pubTimestamp":1786334779,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Mgi Tech Co.,Ltd. (688114.SH) surged over 19% in early trading, currently up 14.27% at 61.51 yuan with a turnover of 1.014 billion yuan.AI for Science is transitioning from concept to an...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159982":"中证500","399300":"沪深300","688114":"华大智造","01477":"欧康维视生物-B","VTHR":"Vanguard Russell 3000 ETF","BK1574":"生物医药B类股","BK1191":"制药","QTOC":"Innovator Growth Accelerated Plus ETF - October","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","AGIX":"通用人工智能 ETF-AGIX","BK0251":"专用设备","AIPO":"Defiance AI and Power Infrastructure ETF","ARTY":"ISHARES FUTURE AI & TECH ETF"},"translate_title":"随着人工智能进入产业化阶段，华大基因科技飙升超过19%，公司为人工智能药物发现提供测序工具","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159982":1,"399300":1,"688114":1,"AGIX":1,"01477":1,"VTHR":1,"ARTY":1,"AIPO":1,"QTOC":1,"CHAT":1},"content_text":"Mgi Tech Co.,Ltd. (688114.SH) surged over 19% in early trading, currently up 14.27% at 61.51 yuan with a turnover of 1.014 billion yuan.AI for Science is transitioning from concept to an industrialization inflection point. Major North American tech firms are collectively doubling down on AI-driven drug development, with accelerated model training and expanded experimental demands feeding upstream. The innovative drug chain is now facing dual opportunities of value reassessment and incremental growth.As a full-stack life science tools provider, Mgi Tech Co.,Ltd. holds a global leading position in full-read-length sequencer business, offering essential sequencing instruments for AI drug discovery. The company previously partnered with Zhuiguang Biotechnology and the National University of Singapore's Department of Pharmacy and Pharmaceutical Sciences in drug research and development.Notably, Mgi Tech Co.,Ltd.'s subsidiary, Yongsheng Intelligence, recently jointly released two achievements with the Shanghai Artificial Intelligence Laboratory: ProtoPilot, a self-evolving multi-agent system driven by real laboratory scenarios, and BioLab Bench, the first full-process Agent evaluation system in life sciences from user requirements to executable equipment, delivering the inaugural Physical AI answer for global life science laboratories.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187311941","isCrawlerRequest":true}